US Weekly IPO and SPAC Monitor: Cybersecurity, Cannabidiol and Psychedelics, Cancer and Pregnancy Therapeutics.

Coming into Year end the IPO market is winding down. This week we have just four IPOs scheduled to raise around $50 million for the week. Cerberus Cyber Sentinel (CISO), Incannex Healthcare (IXHL), Intensity Therapeutics (INTS) and Nuvo Group (NUVO) are expected to debut this week. Cerberus Cyber Sentinel (CISO) Cerberus Cyber Sentinel (CISO) based in Scottsdale, Arizona plans to raise $10 million priced at $5 for a $631 million market cap. The company provides a range of cybersecurity consulting and related services, … Continue reading “US Weekly IPO and SPAC Monitor: Cybersecurity, Cannabidiol and Psychedelics, Cancer and Pregnancy Therapeutics.”

US Weekly IPO and SPAC Monitor : IoT Cloud Solutions Developer Samsara Leads

Coming into Year end the IPO market is winding down. This week we have four IPOs scheduled to raise $814 million for the week. IoT solutions developer (IOT) Samsara, CNS biotech Bionomics (BNOX), Fresh Vine Wine (VINE) and Satellite developer Sidus Space (SIDU) are all expected to debut this week. IoT solutions developer Samsara (IOT) Samsara plans to raise $753 million at an $11.6 billion market cap. Samsara is a developer of end-to-end Internet of Things solutions for businesses and provides a cloud-based platform. The … Continue reading “US Weekly IPO and SPAC Monitor : IoT Cloud Solutions Developer Samsara Leads”

US Weekly IPO and SPAC Monitor : Buffett-backed Brazil’s Nubank Lead

Following the Thanksgiving lull the IPO market is expected to pick up with four IPOs scheduled to raise $3.7 billion for the week. Chicago Atlantic Real Estate Finance (REFI) Cloud infrastructure platform HashiCorp (HCP) Austin Gold (AUST) and Buffett-backed Nu Holdings (NU) debut. Cloud infrastructure platform HashiCorp (HCP) Plans to raise $1.1 billion at a $14.0 billion market cap. This VC-backed company provides a suite of solutions that standardize and automate the provisioning, securing, connecting, and running of cloud infrastructure at scale. While it has demonstrated rapid growth and … Continue reading “US Weekly IPO and SPAC Monitor : Buffett-backed Brazil’s Nubank Lead”

US Weekly IPO and SPAC Monitor : Just One IPO Biotech Nuvectis Pharma

Following Thanksgiving week we have just one IPO due. Phase 1-ready biotech Nuvectis Pharma ($NVCT) plans to raise $30 million at a $160 million market cap.  Be aware there is still a chance that a handful of SPACs will price during the week. Phase 1-ready biotech Nuvectis Pharma ($NVCT) plans to raise $30 million at a $160 million market cap. The company is initially focused the development of innovative precision medicines for the treatment of serious unmet medical needs in oncology. Nuvectis is currently … Continue reading “US Weekly IPO and SPAC Monitor : Just One IPO Biotech Nuvectis Pharma”

Amgen to Buy Human Heavy Chain Antibodies Biotech Teneobio

Amgen today announced it will acquire privately held, clinical stage biotechnology company Teneobio in a deal that includes a $900 million upfront cash payment, plus future contingent milestone payments. Complements $AMGN Antibody Research Capabilities Across Therapeutic Areas.

U.S. The World’s Largest Medical Device Market and Export Leader

The medical device market in the U.S is the largest in the world with a market size of near $156 billion that is around 40 percent of the medical technology market with U.S. exports over $41 billion in 2017 the Department of Commerce shows.